Literature DB >> 11531417

Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export.

X Huang1, T Liu, J Muller, R A Levandowski, Z Ye.   

Abstract

The formation of influenza virus ribonucleoprotein (RNP) is a necessary step in viral assembly and maturation in infected cells, but the mechanism remains incompletely understood. Influenza virus proteins such as matrix (M1) and cellular proteins have been implicated in assembly and transport of RNP. To study the assembly of RNP and the translocation of RNP complexes in cells, RNPs were reconstituted from nucleoprotein (NP), M1, and viral RNA (vRNA) synthesized in vitro. The syntheses were accomplished using specific plasmids in a system coupling transcription and translation under the control of the T7 promoter. The density of the resulting RNP complexes was analyzed by glycerol gradient centrifugation and the morphology was examined by transmission electron microscopy. Protomers of NP self-assembled into circular oligomers regardless of the presence of vRNA or M1. However, helical structures similar in conformation and density to RNPs purified directly from influenza virus were formed only when M1 and vRNA were also present. In the absence of vRNA, no helical structures were formed from NP and M1. The plasmids also contained the CMV promoter, which permitted expression of M1, NP, and vRNA in Madin-Darby canine kidney (MDCK). M1 and NP were both present in the cytoplasm of MDCK also expressing vRNA, but NP was retained in the nucleus of cells expressing M1 without vRNA. Our data demonstrate for the first time that vRNA and M1 together promote the self-assembly of influenza virus NP into the quaternary helical structure typical of the viral RNP. The results also indicate that the interaction of NP with vRNA and M1 in a system devoid of other viral proteins can lead to translocation of RNP from nucleus to cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531417     DOI: 10.1006/viro.2001.1067

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42.

Authors:  Eric Ka-Wai Hui; Subrata Barman; Dominic Ho-Ping Tang; Bryan France; Debi P Nayak
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  New insights into the nuclear localization of retroviral Gag proteins.

Authors:  Leslie J Parent
Journal:  Nucleus       Date:  2011 Mar-Apr       Impact factor: 4.197

5.  Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.

Authors:  Chutikarn Chaimayo; Tsuyoshi Hayashi; Andrew Underwood; Erin Hodges; Toru Takimoto
Journal:  Virology       Date:  2017-02-17       Impact factor: 3.616

6.  Attenuating mutations of the matrix gene of influenza A/WSN/33 virus.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection.

Authors:  Mark A Chua; Sonja Schmid; Jasmine T Perez; Ryan A Langlois; Benjamin R Tenoever
Journal:  Cell Rep       Date:  2013-01-17       Impact factor: 9.423

Review 9.  Cell models for studying renal physiology.

Authors:  M Bens; A Vandewalle
Journal:  Pflugers Arch       Date:  2008-04-22       Impact factor: 3.657

10.  Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.

Authors:  Stephen Mark Tompkins; Zi-Shan Zhao; Chia-Yun Lo; Julia A Misplon; Teresa Liu; Zhiping Ye; Robert J Hogan; Zhengqi Wu; Kimberly A Benton; Terrence M Tumpey; Suzanne L Epstein
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.